These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 7621437)
41. In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemia. Kamath NS; Chitnis MP Oncology; 1990; 47(2):166-9. PubMed ID: 2314829 [TBL] [Abstract][Full Text] [Related]
42. Evaluation of a platinum-doxorubicin complex in experimental tumor systems. Zunino F; Pratesi G; Formelli F; Pasini A Invest New Drugs; 1990 Nov; 8(4):341-5. PubMed ID: 2084067 [TBL] [Abstract][Full Text] [Related]
44. Comparison of adriamycin with DNA-adriamycin complex in chemotherapy of experimental tumors and metastases. Atassi G; Duarte-Karim M; Tagnon HJ Eur J Cancer (1965); 1975 May; 11(5):309-16. PubMed ID: 1157820 [No Abstract] [Full Text] [Related]
45. Influence of supplemental ascorbate on the antitumor activity of 5-hydroxydopa, a purported cytotoxic metabolite. Pierson HF; Meadows GG Cancer Lett; 1985 Nov; 29(2):157-68. PubMed ID: 3935310 [TBL] [Abstract][Full Text] [Related]
46. Phthalocyanine fluorescence in tumors during PDT. Moan J; Anholt H Photochem Photobiol; 1990 Mar; 51(3):379-81. PubMed ID: 2356234 [TBL] [Abstract][Full Text] [Related]
47. [Models of preclinical studies of anthracyclines]. Fizames C Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of tumor growth and metastasis in association with modification of immune response by novel organic germanium compounds. Sato I; Yuan BD; Nishimura T; Tanaka N J Biol Response Mod; 1985 Apr; 4(2):159-68. PubMed ID: 3998767 [TBL] [Abstract][Full Text] [Related]
49. [The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin]. Donenko FV; Sitdikova SM; Kabieva AO Biull Eksp Biol Med; 1993 Sep; 116(9):309-11. PubMed ID: 8118011 [TBL] [Abstract][Full Text] [Related]
50. In vivo light transmission spectra in EMT6/Ed murine tumors and Dunning R3327 rat prostate tumors during photodynamic therapy. Ballangrud AM; Barajas O; Georgousis A; Miller GG; Moore RB; McPhee MS; Tulip J Lasers Surg Med; 1997; 21(2):124-33. PubMed ID: 9261789 [TBL] [Abstract][Full Text] [Related]
51. Potentiation of the anti-tumor effect of actinomycin D by tumor necrosis factor alpha in mice: correlation between in vitro and in vivo results. Lasek W; Giermasz A; Kuc K; Wańkowicz A; Feleszko W; Gołab J; Zagozdzon R; Stokłosa T; Jakóbisiak M Int J Cancer; 1996 May; 66(3):374-9. PubMed ID: 8621260 [TBL] [Abstract][Full Text] [Related]
52. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice. Shimomura K; Manda T; Mukumoto S; Masuda K; Nakamura T; Mizota T; Matsumoto S; Nishigaki F; Oku T; Mori J Cancer Res; 1988 Mar; 48(5):1166-72. PubMed ID: 3342397 [TBL] [Abstract][Full Text] [Related]
53. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery? Darro F; Decaestecker C; Gaussin JF; Mortier S; Van Ginckel R; Kiss R Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908 [TBL] [Abstract][Full Text] [Related]
54. Dendrimer phthalocyanine-encapsulated polymeric micelle-mediated photochemical internalization extends the efficacy of photodynamic therapy and overcomes drug-resistance in vivo. Lu HL; Syu WJ; Nishiyama N; Kataoka K; Lai PS J Control Release; 2011 Nov; 155(3):458-64. PubMed ID: 21689700 [TBL] [Abstract][Full Text] [Related]
55. Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines. Sladek NE; Landkamer GJ Cancer Res; 1985 Apr; 45(4):1549-55. PubMed ID: 3978623 [TBL] [Abstract][Full Text] [Related]
56. Tissue-protective activity of selenomethionine and D-panthetine in B16 melanoma-bearing mice under doxorubicin treatment is not connected with their ROS scavenging potential. Panchuk RR; Skorokhyd NR; Kozak YS; Lehka LV; Moiseenok AG; Stoika RS Croat Med J; 2017 Apr; 58(2):171-184. PubMed ID: 28409500 [TBL] [Abstract][Full Text] [Related]
57. In vivo antitumor activity of sparsomycin and its analogues in eight murine tumor models. Zylicz Z; Wagener DJ; van Rennes H; van der Kleijn E; Lelieveld P; van den Broek LA; Ottenheijm HC Invest New Drugs; 1988 Dec; 6(4):285-92. PubMed ID: 3229941 [TBL] [Abstract][Full Text] [Related]
58. Antitumor effect of kazusamycin B on experimental tumors. Yoshida E; Komiyama K; Naito K; Watanabe Y; Takamiya K; Okura A; Funaishi K; Kawamura K; Funayama S; Umezawa I J Antibiot (Tokyo); 1987 Nov; 40(11):1596-604. PubMed ID: 3693127 [TBL] [Abstract][Full Text] [Related]
59. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow. Chan WS; Brasseur N; La Madeleine C; van Lier JE Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717 [TBL] [Abstract][Full Text] [Related]